Tarsus Pharma

$13.41 0.00% ($0.00)

Get ready to invest

About Tarsus Pharma

Tarsus Pharmaceuticals Inc. is a late clinical-stage biopharmaceutical company. The Company if focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. Its lead product candidate, TP-03, is a novel therapeutic being developed for the treatment of blepharitis caused by the infestation of Demodex mites (Demodex blepharitis). It is developing TP-03 as an eye drop. It is also focused on developing additional clinical-stage product candidates, including TP-04 and TP-05. TP-04 is being developed for the treatment of rosacea and TP-05 for Lyme prophylaxis and community malaria reduction.

Popular Stocks	Price	Change
Nu Holdings NU	$4.33 13.35%	13.35%
Annaly NLY	$6.27 1.42%	1.42%
AMD AMD	$96.67 0.41%	0.41%
Nvidia NVDA	$171.24 1.1%	1.1%
SoFi Technologies, Inc. SOFI	$7.75 7.19%	7.19%
Ford F	$12.85 0.55%	0.55%
Apple AAPL	$137.35 2.46%	2.46%
Cisco CSCO	$41.72 13.73%	13.73%
Grab Holdings inc. GRAB	$3.14 24.11%	24.11%
NIO NIO	$16.66 5.24%	5.24%